![]()
Palliser Capital (“Palliser”), whose funds have an economic interest equivalent to approximately 3% of Chemring Group PLC (LSE: CHG) (“Chemring” or the “Company”), making it one of the Company’s ten largest investors, today published a letter to Chemring’s Board of Directors (the “Board”) calling for a comprehensive strategic review, including the potential sale or separation of Roke and the capital and ownership arrangements best suited to accelerating growth in Energetics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118387069/en/
Chemring owns some of the most strategically important assets in the Western defence industrial base. It is one of only two manufacturers of advanced military explosives in Europe, and supplies countermeasures to 85% of NATO’s air fleets. Yet since 2022, the strongest period for defence equities in modern history, Chemring has underperformed its European-listed defence peers by approximately 400% and delivered virtually no earnings growth for its shareholders.
In its letter, Palliser argues that a lack of focus and a conglomerate structure are holding Chemring back. Energetics, where capacity is sold out for years and new investments earn returns of over 20%, is competing for capital with Roke, a U.K.-focused technical consultancy that again fell short of expectations this month due to U.K. procurement delays.
James Smith, Chief Investment Officer of Palliser, said:
“Chemring owns some of the scarcest assets in Western defence at the very moment allied governments need them most, yet its shareholders have been left behind. With a record order book and a new CEO about to take office, the Board has a clear opportunity to act from a position of strength. A strategic review that focuses Chemring on Energetics and allows Roke to thrive under the right ownership could, in our view, deliver upside of 64% to 80% within the next twelve months. We look forward to engaging constructively with the Board.”
In its letter, Palliser calls on the Board to:
- launch a comprehensive strategic review, with every option on the table;
- pursue the sale or separation of Roke, which would be worth considerably more to a strategic owner;
- accelerate investment in Energetics, where demand far exceeds capacity; and
- expand Chemring’s presence in the U.S. and international markets, including the Gulf and Indo-Pacific.
Full details of Palliser’s letter to the Board are outlined in the accompanying attachment.
A copy of Palliser’s presentation on Chemring at the Annual Sohn London Investment Conference is available here.
About Palliser Capital
Palliser is an alternative investment manager that applies a value-oriented, event-driven philosophy to investing across a range of distinct yet complementary strategies on a global basis with a focus on situations where positive change and value enhancement can be achieved through thoughtful, constructive, and long-term engagement with companies and across a range of different stakeholder groups.
Important Notice
Palliser Capital (UK) Ltd (“Palliser UK”) is registered in England and Wales and authorised and regulated by the United Kingdom Financial Conduct Authority (“FCA”).
The views expressed in this press release and the linked materials (“Materials”) represent the opinions of Palliser UK and its affiliates (collectively, “Palliser”) as of the date hereof. Palliser reserves the right to change or modify any of its opinions expressed in the Materials at any time and for any reason and expressly disclaims any obligation to correct, update or revise the information contained in the Materials or to otherwise provide any additional information.
The views expressed in the Materials do not constitute (a) an offer or invitation to buy or sell, or a solicitation of an offer to buy or sell or to otherwise engage in any investment business or provide or receive any investment services in respect of, any security or other financial instrument and no legal relations shall be created by its issue, (b) a “Financial Promotion” for the purposes of the Financial Services and Markets Act 2000 of the UK (as amended), (c) “Investment Advice” as defined by the FCA Handbook of rules and guidance (“FCA Handbook”), (d) “Investment Research” as defined by the FCA Handbook, or (e) an “Investment Recommendation” as defined by Regulation (EU) 596/2014 and by Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of Section 3 of the European Union (Withdrawal) Act 2018 (“EUWA 2018”), including as amended by regulations issued under Section 8 of EUWA 2018. No information contained in the Materials should be construed as a recommendation by Palliser, and the Materials are not intended to form the basis of any investment decision or suggest an investment strategy. They are not (and may not be construed to be) legal, tax, investment, financial or other advice.
The information contained in the Materials is based on publicly available information with respect to Chemring Group PLC and the other companies referred to herein and Palliser’s analysis of such publicly available information. Palliser has relied upon and assumed, without independent verification, the reliability, accuracy and completeness of all data and information available from public sources, and no representation or warranty is made that any such data or information is accurate. Palliser recognizes that each company may possess confidential or otherwise non-public information that could lead it to disagree with Palliser’s views and/or conclusions and that could alter the opinions of Palliser were such information known.
No representation, warranty or undertaking, express or implied, is given and no responsibility or liability or duty of care is or will be accepted by Palliser concerning whether the information and opinions expressed in the Materials are accurate, fair, complete or current or the provision of any further information, whether by way of update to the information and opinions contained herein.
Investment vehicle(s) advised or managed by Palliser have a direct or indirect investment in Chemring Group PLC. Accordingly, Palliser may have conflicts of interest and the views expressed herein should not be regarded as impartial.
Palliser may from time to time (in the open market or in private transactions) buy, sell, cover, hedge or otherwise change the form or substance of any such investment(s) to any degree in any manner permitted by law and expressly disclaims any obligation to notify others of any such changes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118387069/en/
Media gallery